Tomorrow we have an emerging growth call and the o
Post# of 148163
Personally I would like to find out the following:
What are the specific issues causing the further delay regarding the resubmission of the BLA? What progress have we made toward the resubmission over the past year, and regarding the outstanding issues what is being done to address them.
I remember on the last call I believe it was mentioned that we were locked out from our data. I'm wondering if that is still the case?
I hope that tomorrow's call makes us pleasantly surprised so we can get this life saving drug to as many people as possible.